Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings

ConditionSubstance Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

The goal of this study is to learn whether a virtual peer recovery coach (PRC) intervention can improve engagement in addiction treatment among incarcerated adults with substance use disorders.

The main questions it aims to answer are:

* Does the PRC intervention increase engagement with at least one recovery resource at 30 and 90 days? * Does it improve secondary outcomes such as substance use, recovery capital, overdose events, and recidivism?

Researchers will compare Treatment-as-Usual with the PRC telehealth intervention to see if PRC support improves engagement in addiction care.

Participants will:

* Complete baseline and follow-up assessments * Receive either Treatment-as-Usual or a virtual PRC session focused on motivational interviewing and linkage to recovery resources

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Incarcerated at participating jail

Able to speak and understand English

Score of 3 or greater - "moderate level", "substantial level", or "severe level" of problems related to drug abuse - on DAST-10.

Willing to follow study procedures and complete research follow-up calls

Disqualifiers

Cognitive impairment (inability to comprehend the informed consent document as assessed by study staff during enrollment)

Prior participation in the study

Awaiting transfer to prison or jail outside the state of Georgia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual Peer Recovery Coaching

    Behavioral

    A telehealth session with a peer recovery coach who provides motivational interviewing and tailored linkage to addiction treatment and recovery resources.

  • Treatment as Usual

    Behavioral

    Participants are provided information about community-based addiction treatment and recovery resources as part of routine jail processes.

Treatment groups

550 Participants
are divided into 2 treatment groups
Group A: PRC groupExperimental treatment 1 intervention
Group B: Standard of CareActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Engagement With at Least One Recovery Resource

Engagement with at least one recovery resource, defined as: * Formal addiction treatment (visit with a physician, psychologist, or licensed substance use counselor; or ≥1 night in detoxification or residential treatment), or * Recovery Community Organization (RCO) participation (contact, intake, and participation in ≥1 evidence-based recovery activity), or * Harm reduction organization engagement. Engagement may occur during incarceration or in the community after release.

Time frame
30 days and 90 days after enrollment

Secondary outcomes

1

Days Receiving Medications for Substance Use Disorders

Number of days participants receive medications for opioid use disorder (MOUD), stimulant use disorder, or alcohol use disorder.

Time frame
Baseline to 30 days, 90 days, 180 days, and 1 year
2

Recidivism and Justice Involvement

New arrests, bookings, or jail stays documented through participant report or administrative data.

Time frame
Baseline to 1 year
3

Healthcare Utilization

Emergency department visits, hospitalizations, and other acute care encounters.

Time frame
Baseline to 1 year
4

Recovery Capital (BARC-10)

Brief Assessment of Recovery Capital (BARC-10) A 10-item validated scale that measures a person's internal and external resources that support recovery from substance use. Items assess domains such as social support, coping skills, housing stability, and personal motivation. * Scores range from 10 to 60. * Higher scores indicate greater recovery capital and stronger readiness to sustain recovery.

Time frame
Baseline, 30, 90, 180 days, and 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Emory University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator